Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 114 páginas
Examen

NR 509 Advanced Physical Assessment Final Exam: Breast Mass Case Study (2026/2027) PDF | Nursing | Chamberlain

Document preview thumbnail
Vista previa 4 fuera de 114 páginas

INSTANT PDF DOWNLOAD. Complete NR 509 Advanced Physical Assessment final exam case study. Features 44-year-old female mathematician with right breast mass, no family history, limited mammogram history, and benign cyst diagnosis. Covers age-appropriate breast cancer screening recommendations. Essential resource for Chamberlain nursing students.

Vista previa del contenido

NR 509 / NR509 Advanced Physical Assessment
Final Exam
Questions with Verified Answers - Chamberlain



Consist of 100 multiple choices Questions with Answers




1. A 44-year-old female mathematician presents to clinic with a complaint

of a mass in the right breast. Her partner noticed this mass 2 days ago, and

the patient feels guilty because she has only had one mammogram and

does not engage in breast self-examination (BSE) on any regular basis. She

has no family history of breast cancer, and her prior mammogram was

ordered as a routine screening test at age 43 years after a brief discussion

with her primary care provider. After a thorough investigation reveals a

benign cyst, what advice should be given to this patient about screening for

breast cancer in her age group?


,a. BSE is well evidenced, and all recommending agencies agree that it should

be taught and reinforced.

b. Clinical breast examination (CBE) is superior to BSE and should be a routine

part of annual examinations starting at age 30 years.

c. This patient was in compliance with the U.S. Preventive Services Task Force

(USPSTF)

recommendations for her age group and risk factors prior to her current

complaint.

d. Mammography is most sensitive and specific for women in their 40s,

when breast tissue is still dense enough to image accurately.

e. Breast cancer screening is extremely well st

ANS c. This patient was in compliance with the U.S. Preventive Services Task

Force (USPSTF)

recommendations for her age group and risk factors prior to her current

complaint.






,2. A 42-year-old female website developer presents for an annual

preventive examination with questions about breast cancer screening. She is

concerned about the radiation exposure associated with mammography and

is interested in magnetic resonance imaging (MRI) as a possible alternative

for routine screening. She is otherwise healthy with no family history of

breast, ovarian, or colon cancer. Which of the following is true about MRI as a

screening modality for breast cancer in the general population?


a. Breast cancer screening by MRI has been well studied in the general

population.

b. Sensitivity of screening for breast cancer increases with breast MRI at the

expense of specificity.

c. This patient is an ideal candidate for screening via breast MRI based on

current evidence

d. Women at low lifetime risk of breast cancer (<20%) are recommended

to undergo screening MRI.


e. Known BRCA1 or BRCA2 mutation is insufficient criteria to justify screening



, with breast MRI.

ANS b. Sensitivity of screening for breast cancer increases with breast MRI at

the expense of specificity.




3. A 35-year-old G0P0 woman presents to clinic with a complaint of bilateral

nipple discharge. This discharge started several weeks ago and has occurred

at irregular intervals since that time. She does not complain of local tender-

ness, redness, fever, or any other systemic symptoms aside from slightly irreg-

ular periods over the last few months. On examination, she is able to express

a small amount of discharge, which is sent to the laboratory and found to

be consistent with breast milk but without any signs of blood or pus.

Screening laboratories are also sent, which reveal a normal blood count,

metabolic panel, thyroid-stimulating hormone, and human chorionic

gonadotropin (HCG) level. Further laboratories are still pending. Which of

the following is the most likely diagnosis?


a. Mastitis

b. Ductal carcinoma in situ

Información del documento

Subido en
15 de marzo de 2026
Número de páginas
114
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$10.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
10
Seguidores
9
Artículos
635
Última venta
1 año hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes